ESCIENT PHARMACEUTICALS
Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus in advancement of first-in-class G Protein-Coupled Receptor targeted drugs. The company's services focuses on offering therapies for neuro-immuno-inflammatory and autoreactive diseases, enabling its clients to receive drugs required for treatment of serious, unserved medical needs across a broad range of therapeutic indications.
ESCIENT PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Founded:
2018-05-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.escientpharma.com
Total Employee:
11+
Status:
Active
Contact:
858.617.8220
Email Addresses:
[email protected]
Total Funding:
117.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Eyebiotech
Eyebiotech is a privately held ophthalmology biotechnology company.
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Escient Pharmaceuticals
Sanofi Ventures
Sanofi Ventures investment in Series B - Escient Pharmaceuticals
Redmile Group
Redmile Group investment in Series B - Escient Pharmaceuticals
The Column Group
The Column Group investment in Series B - Escient Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series B - Escient Pharmaceuticals
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Escient Pharmaceuticals
5AM Ventures
5AM Ventures investment in Series B - Escient Pharmaceuticals
The Column Group
The Column Group investment in Series A - Escient Pharmaceuticals
5AM Ventures
5AM Ventures investment in Series A - Escient Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Escient Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-19 | Escient Pharmaceuticals Appoints Joshua Grass as New CEO |
| 2022-01-05 | Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO |
Official Site Inspections
http://www.escientpharma.com
- Host name: 109.194.224.35.bc.googleusercontent.com
- IP address: 35.224.194.109
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Escient Pharmaceuticals"
Leadership - Escient pharmaceuticals
Most recently, Don was a Senior Vice President in R&D at Allergan where he led an organization responsible for research and preclinical functions, clinical pharmacology, and the scientific arm of business development. He was a …See details»
Escient Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 858.617.8220 Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the …See details»
Overview - Escient pharmaceuticals
We are a privately held, clinical stage biotechnology company advancing novel, differentiated therapeutics for the potential treatment of a broad range of neurosensory-inflammatory …See details»
Escient Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Escient Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Org Chart Escient Pharmaceuticals - The Official Board
The organizational chart of Escient Pharmaceuticals displays its 18 main executives including Joshua Grass, Aaron Mishel, David Houck and Kristin TaylorSee details»
Overview, News & Similar companies - ZoomInfo.com
Nov 28, 2023 Who is Escient Pharmaceuticals. Escient Pharmaceuticals is a clinical-stage, industry-leading platform biotechnology company focused on the discovery and development …See details»
Escient Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Www.escientpharma.com. Startups | Subsidiary Company | 2018 | California, United States | 10-50 | www.escientpharma.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. ... The …See details»
Escient Pharmaceuticals - Employees, Contact info, Overview - Wiza
May 1, 2024 View info about Escient Pharmaceuticals (escientpharma.com). Escient Pharmaceuticals is a company located in San Diego, CA, United States. Find employees, …See details»
Escient Pharmaceuticals CEO and Key Executive Team - Craft
Escient Pharmaceuticals's Chief Executive Officer is Joshua Grass. Other executives include Christian Weyer, Chief Medical Officer; Esther Martinborough, Chief Scientific Officer and 6 …See details»
Escient Pharmaceuticals - Craft
Escient Pharmaceuticals is a pharmaceutical company that develops therapeutics for neurosensory-inflammatory diseases. It offers solutions for patients with chronic urticaria, …See details»
Escient Pharmaceuticals - VentureRadar
"Escient Pharmaceuticals is a biotech company that develops targeted small molecule therapeutics for a broad range of diseases. The firm's primary focus is on Mas-related G …See details»
About Us - Escient pharmaceuticals
10578 Science Center Drive # 250 San Diego, CA 92121. Contact Us. © 2024 Escient Pharmaceuticals | Privacy Policy | Terms of UseSee details»
Escient Pharmaceuticals - LinkedIn
Escient Pharmaceuticals | 3,006 followers on LinkedIn. Targeted therapeutics for neurosensory-inflammatory disorders | Escient is a clinical-stage pharmaceutical company focused on …See details»
Escient Pharmaceuticals - PitchBook
Www.escientpharma.com. Formerly Known As. Mas Therapeutics. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Formerly VC-backed. Corporate …See details»
Escient Pharmaceuticals Company Overview, Contact Details
New Enterprise Associates invested into Escientpharma $120M on Nov 1st '22. New Enterprise Associates, along with Boston’s Abingworth and United Kingdom’s Forge Life Sciences …See details»
Escient Pharmaceuticals - workinbiotech.com
Escient Pharmaceuticals is developing therapeutics that target G-protein coupled receptors (GPCRs) to treat neurosensory inflammatory disorders. GPCRs are cell surface receptors that …See details»
Escient Pharmaceuticals Announces $120 Million Series C …
Financing led by New Enterprise Associates (NEA), Abingworth and Forge Life Science Partners Proceeds support advancement of EP262 and EP547 to multiple clinical milestones SAN …See details»
Ascential Medical & Life Sciences Announces Executive Leadership ...
13 hours ago Ellen Scipta and Chris Cowen join the organization as CFO and CCO, respectively, while Todd Martensen transitions from CCO to CSO. SAN DIEGO, March 26, …See details»
Our Approach - Escient pharmaceuticals
MRGPR Antagonism: A Paradigm-Changing Therapeutic Approach Our industry-leading MRGPR platform encompasses a broad set of capabilities designed to systematically elucidate and …See details»
Join our Team - Escient pharmaceuticals
Open Positions Escient is always looking for passionate and talented individuals to join our team. Please explore our open positions below. View our currently open positions. Job listings …See details»